Breast Cancer Screening Market Size, Share Report 2027
[Research Report] The breast cancer screening market is expected to reach US$ 6,209.25 Mn by 2027 from US$ 4,638.63 Mn in 2019; it is estimated to grow at a CAGR of 4.8% from 2020 to 2027.
Breast cancer is the most common and widely occurring type of cancer among women; it develops in breast tissues, usually in the ducts (tubes that carry milk to the nipple) and lobules (glands that make milk). It can also occur in the fatty tissue or fibrous connective tissue within breasts. Early diagnosis of breast cancer is important as it may prevent the condition from becoming critical and ensure a successful curable treatment. The screening methods for the diagnosis of breast cancer include mammography, magnetic resonance imaging (MRI), ultrasound, and others. The foremost goal of screening is to detect disease at its earliest and most treatable stage. The screening procedures identify the early signs of cancer, even before the symptoms begin to show.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Breast Cancer Screening Market: Strategic Insights
Market Size Value in US$ 4,638.63 Million in 2019 Market Size Value by US$ 6,209.25 Million by 2027 Growth rate CAGR of 4.8% from 2020-2027 Forecast Period 2020-2027 Base Year 2020
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Breast Cancer Screening Market: Strategic Insights
| Market Size Value in | US$ 4,638.63 Million in 2019 |
| Market Size Value by | US$ 6,209.25 Million by 2027 |
| Growth rate | CAGR of 4.8% from 2020-2027 |
| Forecast Period | 2020-2027 |
| Base Year | 2020 |
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Market Insights
Globally Growing Breast Cancer Prevalence
Breast cancer is among the prime causes of deaths in the world, and it is profoundly affecting the quality of life. Thus, it acts as a burden on society if not diagnosed and treated on time. As per the estimations by the American Cancer Society, breast cancer is the most common type of cancer in the US as it caused morbidity in ~234,087 people and lead to 41,904 deaths in 2018. Further, ~276,480 new cases are expected in the country in 2020. As per the Globocan 2019 report, in Germany, the total number of breast cancer cases in 2018 was 71,888, and around the disease lead to ~19,376 deaths in that year. Further, as per the Globocan report, in 2018, there were ~367,900 new cases of breast cancer and 97,972 deaths due to the same in China. In India, NGOs, government agencies, and charity organizations are emphasizing on breast cancer awareness among population to promote early detection, provide comprehensive treatment module, and extend support for breast cancer management. Such initiatives are a result of the increasing prevalence of this type of cancer in the country. As per the Globocan report estimation, in 2018, India reported ~162,468 new breast cancer cases and 87,090 deaths due to the same. Such growing prevalence of breast cancer in different regions around the world is raising the global demand for the screening devices for the same.
Test Type-Based Market Insights
The breast cancer screening market, by product type, is segmented into blood marker tests, imaging test, genetic test, immunohistochemistry test. The imaging test segment held the largest share of the market in 2019, and it is also anticipated to register the highest CAGR in the market during the forecast period.
End-User-Based Insights
On the basis of end user, the breast cancer screening market has been segmented into hospitals, diagnostic centers, cancer institutes, and research laboratories. The hospitals segment held the largest share of the market in 2019, whereas the diagnostic centers segment is estimated to register the highest CAGR in the market during the forecast period.
Product launches and approvals is a commonly adopted strategy by companies in the breast cancer screening market to expand their footprint worldwide and meet the growing demand by enlarging their product portfolios. They also adopt the strategy of expansion to enlarge customer base across the world, which also permits them to maintain their brand name globally. For instance, in June 2017, Siemens Healthineers received Food and Drug Administration (FDA) approval of product namely syngo.via VB20 which is likely to use for for Molecular Imaging (MI) from Siemens Healthineers — a new release of the company’s established intelligent visualization software for multi-modality imaging.
Breast Cancer Screening Market Report Scope
Breast Cancer Screening Market – By Product Type
- Blood Marker Test
- Imaging Test
- Genetic Test
- Immunohistochemistry Test
Breast Cancer Screening Market – By Application
- Diagnostic Centers
- Hospitals
- Research Laboratories
- Cancer Institutes
Breast Cancer Screening – By Geography
- North America
- US
- Canada
- Mexico
- Europe
- France
- Germany
- Italy
- UK
- Spain
- Rest of Europe
- Asia Pacific
- China
- India
- South Korea
- Japan
- Australia
- Rest of Asia Pacific
- Middle East and Africa
- South Africa
- Saudi Arabia
- UAE
- Rest of Middle East and Africa
- South America
- Brazil
- Argentina
- Rest of South America
Company Profiles
- General Electric Company
- Siemens Healthineers AG
- Exact Sciences Corporation
- Koninklijke Philips N.V.
- Hologic, Inc.
- BD
- Myriad Genetics, Inc.
- Oncocyte Corporation
- Danaher
- POC Medical Systems
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Test Type ; End User , and Geography
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States
Frequently Asked Questions
The North American region holds the largest market for the breast cancer screening. The United States held the largest market for breast cancer screening mean market and is expected to grow due to factors such as increasing number of rising in prevalence of breast cancer, growing developments for screening and imaging process by the companies and others.
The diagnosis of breast cancer is done through breast cancer screening methods such as mammography, magnetic resonance imaging (MRI), ultrasound, and others. Screening examinations are tests performed for early diagnosis of the disease. The foremost goal of screening is to detect disease at its earliest and most treatable stage.
The growth of the market is attributed to some key driving factors such as increasing number of breast cancer cases, growing geriatric population and rising adoption of technology for screening purpose. However, high cost of screening method and bassinet on global business due to coronavirus pandemic are expected to restraint the growth of the market during the forecast years.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Breast Cancer Screening Market – By Test Type
1.3.2 Global Breast Cancer Screening Market – By End User
1.3.3 Global Breast Cancer Screening Market – By Geography
2. Breast Cancer Screening Market – Key Takeaways
2.1 Global Breast Cancer Screening Market Overview
2.2 Global Breast Cancer Screening Market, By Geography (US$ Million)
2.3 Global Breast Cancer Screening Market- Leading Country Markets (US$ Million)
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Breast Cancer Screening – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America – PEST Analysis
4.2.2 Europe – PEST Analysis
4.2.3 Asia Pacific – PEST Analysis
4.2.4 Middle East and Africa (MEA) – PEST Analysis
4.2.5 South and Central America (SCAM) – PEST Analysis
4.3 Expert Opinion
5. Breast Cancer Screening– Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Globally Growing Breast Cancer Prevalence
5.1.2 Increasing Investments in Breast Cancer Management
5.2 Key Market Restraints
5.2.1 High Cost of Breast Cancer Screening
5.3 Key Market Opportunities
5.3.1 Emerging Markets in Developing Countries
5.4 Future Trends
5.4.1 Consistent Launch of New Screening Products
5.5 Impact Analysis
6. Breast Cancer Screening Market – Global Analysis
6.1 Global Breast Cancer Screening Market Revenue Forecast and Analysis
6.2 Global Breast cancer screening Market, By Geography - Forecast and Analysis
6.3 Market Positioning of Key Players
7. Breast Cancer Screening Market Analysis – By Test Type
7.1 Overview
7.2 Breast Cancer Screening Market Revenue Share, by Test Type (2019 and 2027)
7.3 Blood Marker Test
7.3.1 Overview
7.3.2 Blood Marker Tests:Breast Cancer Screening Market – Revenue and Forecast to 2027 (US$ Million)
7.5 Imaging Test
7.5.1 Overview
7.5.2 Imaging Test: Breast Cancer Screening Market– Revenue and Forecast to 2027 (US$ Million)
7.6 Genetic Test
7.6.1 Overview
7.6.2 Genetic Test: Breast Cancer Screening Market – Revenue and Forecast to 2027 (US$ Million)
7.7 Immunohistochemistry Test
7.7.1 Overview
7.7.2 Immunohistochemistry Test: Breast Cancer Screening Market – Revenue and Forecast to 2027 (US$ Million)
8. Breast Cancer Screening Market – By End User
8.1 Overview
8.2 Breast Cancer Screening Market, by End-User, 2019 and 2027 (%)
8.3 Hospitals
8.3.1 Overview
8.3.2 Hospitals: Breast Cancer Screening Market – Revenue and Forecast to 2027 (US$ Million)
8.4 Diagnostics Centers
8.4.1 Overview
8.4.2 Diagnostic Centers: Breast Cancer Screening Market – Revenue and Forecast to 2027 (US$ Million)
8.5 Research Laboratories
8.5.1 Overview
8.6 Research Laboratories: Breast Cancer Screening Market – Revenue and Forecast to 2027 (US$ Million)
8.7 Cancer Institutes
8.7.1 Overview
8.8 Cancer Institutes: Breast Cancer Screening Market – Revenue and Forecast to 2027 (US$ Million)
9. Breast Cancer Screening Market – Geographic Analysis
9.1 North America: Breast Cancer Screening Market
9.1.1 Overview
9.1.2 North America: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)
9.1.3 North America: Breast Cancer Screening Market, by Test Type, 2018–2027 (USD Million)
9.1.4 North America: Breast Cancer Screening Market, by End User, 2018–2027 (USD Million)
9.1.5 North America: Breast Cancer Screening Market, by Country, 2019 & 2027 (%)
9.1.6 US: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)
9.1.6.1 US: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)
9.1.6.2 US: Breast Cancer Screening Market, by Test Type, 2018–2027 (USD Million)
9.1.6.3 US: Breast Cancer Screening Market, by End User, 2018–2027 (USD Million)
9.1.7 Canada: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)
9.1.7.1 Canada: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)
9.1.7.2 Canada: Breast Cancer Screening Market, by Test Type, 2018–2027 (USD Million)
9.1.7.3 Canada: Breast Cancer Screening Market, by End User, 2018–2027 (USD Million)
9.1.8 Mexico: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)
9.1.8.1 Mexico: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)
9.1.8.2 Mexico: Breast Cancer Screening Market, by Test Type, 2018–2027 (USD Million)
9.1.8.3 Mexico: Breast Cancer Screening Market, by End User, 2018–2027 (USD Million)
9.2 Europe: Breast Cancer Screening Market
9.2.1 Overview
9.2.2 Europe: Breast Cancer Screening Market - Revenue and Forecast to 2027 (USD Million)
9.2.3 Europe: Breast Cancer Screening Market, by Test Type, 2018–2027 (USD Million)
9.2.4 Europe: Breast Cancer Screening Market, by End User, 2018–2027 (USD Million)
9.2.5 Europe: Breast Cancer Screening Market, by Country, 2018 & 2027 (%)
9.2.6 Germany: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)
9.2.6.1 Germany: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)
9.2.6.2 Germany: Breast Cancer Screening Market, by Test Type, 2018–2027 (USD Million)
9.2.6.3 Germany: Breast Cancer Screening Market, by End User, 2018–2027 (USD Million)
9.2.7 UK: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)
9.2.7.1 UK: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)
9.2.7.2 UK: Breast Cancer Screening Market, by Test Type, 2018–2027 (USD Million)
9.2.7.3 UK: Breast Cancer Screening Market, by End User, 2018–2027 (USD Million)
9.2.8 France: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)
9.2.8.1 France: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)
9.2.8.2 France: Breast Cancer Screening Market, by Test Type, 2018–2027 (USD Million)
9.2.8.3 France: Breast Cancer Screening Market, by End User, 2018–2027 (USD Million)
9.2.9 Spain: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)
9.2.9.1 Spain: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)
9.2.9.2 Spain: Breast Cancer Screening Market, by Test Type, 2018–2027 (USD Million)
9.2.9.3 Spain: Breast Cancer Screening Market, by End User, 2018–2027 (USD Million)
9.2.10 Italy: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)
9.2.10.1 Italy: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)
9.2.10.2 Italy: Breast Cancer Screening Market, by Test Type, 2018–2027 (USD Million)
9.2.10.3 Italy: Breast Cancer Screening Market, by End User, 2018–2027 (USD Million)
9.3 Asia Pacific: Breast Cancer Screening Market
9.3.1 Overview
9.3.2 Asia Pacific: Breast Cancer Screening Market - Revenue and Forecast to 2027 (USD Million)
9.3.3 Asia Pacific: Breast Cancer Screening Market, by Test Type, 2018–2027 (USD Million)
9.3.4 Asia Pacific: Breast Cancer Screening Market, by End User, 2018–2027 (USD Million)
9.3.5 Asia Pacific: Breast Cancer Screening Market, by Country, 2018 & 2027 (%)
9.3.6 China: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)
9.3.6.1 China: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)
9.3.6.2 China: Breast Cancer Screening Market, by Test Type, 2018–2027 (USD Million)
9.3.6.3 China: Breast Cancer Screening Market, by End User, 2018–2027 (USD Million)
9.3.7 Japan: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)
9.3.7.1 Japan: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)
9.3.7.2 Japan: Breast Cancer Screening Market, by Test Type, 2018–2027 (USD Million)
9.3.7.3 Japan: Breast Cancer Screening Market, by End User, 2018–2027 (USD Million)
9.3.8 India: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)
9.3.8.1 India: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)
9.3.8.2 India: Breast Cancer Screening Market, by Test Type, 2018–2027 (USD Million)
9.3.8.3 India: Breast Cancer Screening Market, by End User, 2018–2027 (USD Million)
9.3.9 South Korea: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)
9.3.9.1 South Korea: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)
9.3.9.2 South Korea: Breast Cancer Screening Market, by Test Type, 2018–2027 (USD Million)
9.3.9.3 South Korea: Breast Cancer Screening Market, by End User, 2018–2027 (USD Million)
9.3.10 Australia: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)
9.3.10.1 Australia: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)
9.3.10.2 Australia: Breast Cancer Screening Market, by Test Type, 2018–2027 (USD Million)
9.3.10.3 Australia: Breast Cancer Screening Market, by End User, 2018–2027 (USD Million)
9.4 Middle East & Africa: Breast Cancer Screening Market
9.4.1 Overview
9.4.2 Middle East & Africa: Breast Cancer Screening Market - Revenue and Forecast to 2027 (USD Million)
9.4.3 Middle East & Africa: Breast Cancer Screening Market, by Test Type, 2018–2027 (USD Million)
9.4.4 Middle East & Africa: Breast Cancer Screening Market, by End User, 2018–2027 (USD Million)
9.4.5 Middle East & Africa: Breast Cancer Screening Market Share by Country – 2019 & 2027, (%)
9.4.6 Saudi Arabia: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)
9.4.6.1 Saudi Arabia: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)
9.4.6.2 Saudi Arabia: Breast Cancer Screening Market, by Test Type, 2018–2027 (USD Million)
9.4.6.3 Saudi Arabia: Breast Cancer Screening Market, by End User, 2018–2027 (USD Million)
9.4.7 UAE: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)
9.4.7.1 UAE: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)
9.4.7.2 UAE: Breast Cancer Screening Market, by Test Type, 2018–2027 (USD Million)
9.4.7.3 UAE: Breast Cancer Screening Market, by End User, 2018–2027 (USD Million)
9.4.8 South Africa: Breast Cancer Screening Market – Revenue and Forecast to 2027 (US$ Million)
9.4.8.1 South Africa: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)
9.4.8.2 South Africa: Breast Cancer Screening Market, by Test Type, 2018–2027 (USD Million)
9.4.8.3 South Africa: Breast Cancer Screening Market, by End User, 2018–2027 (USD Million)
9.5 South and Central America: Breast Cancer Screening Market
9.5.1 Overview
9.5.2 South and Central America: Breast Cancer Screening Market - Revenue and Forecast to 2027 (US$ Million)
9.5.3 South and Central America: Breast Cancer Screening Market, by Test Type, 2018–2027 (USD Million)
9.5.4 South and Central America: Breast Cancer Screening Market, by End User, 2018–2027 (USD Million)
9.5.5 South and Central America: Breast Cancer Screening Market, by Country, 2018 & 2027 (%)
9.5.6 Brazil: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)
9.5.6.1 Brazil: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)
9.5.6.2 Brazil: Breast Cancer Screening Market, by Test Type, 2018–2027 (USD Million)
9.5.6.3 Brazil: Breast Cancer Screening Market, by End User, 2018–2027 (USD Million)
9.5.7 Argentina: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)
9.5.7.1 Argentina: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)
9.5.7.2 Argentina: Breast Cancer Screening Market, by Test Type, 2018–2027 (USD Million)
9.5.7.3 Argentina: Breast Cancer Screening Market, by End User, 2018–2027 (USD Million)
10. Impact Of COVID-19 Pandemic On Global Breast Cancer Screening Market
10.1 North America: Impact Assessment of COVID-19 Pandemic
10.2 Europe: Impact Assessment Of COVID-19 Pandemic
10.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
10.4 Rest of the World: Impact Assessment of COVID-19 Pandemic
11. Breast Cancer Screening Market –Industry Landscape
11.1 Overview
11.2 Growth Strategies in The Breast Cancer Screening Market, 2016-2020
11.3 Inorganic Growth Strategies
11.3.1 Overview
11.4 Organic Growth Strategies
11.4.1 Overview
12. Breast Cancer Screening Market – Key Company Profiles
12.1 General Electric Company
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Siemens Healthineers AG
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Exact Sciences Corporation
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Koninklijke Philips N.V.
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Hologic, Inc.
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 BD
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Myriad Genetics, Inc.
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Oncocyte Corporation
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Danaher
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 POC Medical Systems
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About the Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. North America Breast Cancer Screening Market, by Test Type– Revenue and Forecast to 2027 (USD Million)
Table 2. North America Breast Cancer Screening Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 3. US Breast Cancer Screening Market, by Test Type – Revenue and Forecast to 2027 (USD Million)
Table 4. US Breast Cancer Screening Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 5. Canada Breast Cancer Screening Market, by Test Type – Revenue and Forecast to 2027 (USD Million)
Table 6. Canada Breast Cancer Screening Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 7. Mexico Breast Cancer Screening Market, by Test Type – Revenue and Forecast to 2027 (USD Million)
Table 8. Mexico Breast Cancer Screening Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 9. Europe Breast Cancer Screening Market, by Test Type– Revenue and Forecast to 2027 (USD Million)
Table 10. Europe Breast Cancer Screening Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 11. Germany Breast Cancer Screening Market, by Test Type – Revenue and Forecast to 2027 (USD Million)
Table 12. Germany Breast Cancer Screening Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 13. UK Breast Cancer Screening Market, by Test Type – Revenue and Forecast to 2027 (USD Million)
Table 14. UK Breast Cancer Screening Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 15. France Breast Cancer Screening Market, by Test Type – Revenue and Forecast to 2027 (USD Million)
Table 16. France Breast Cancer Screening Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 17. Spain Breast Cancer Screening Market, by Test Type – Revenue and Forecast to 2027 (USD Million)
Table 18. Spain Breast Cancer Screening Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 19. Italy Breast Cancer Screening Market, by Test Type – Revenue and Forecast to 2027 (USD Million)
Table 20. Italy Breast Cancer Screening Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 21. Asia Pacific Breast Cancer Screening Market, by Test Type– Revenue and Forecast to 2027 (USD Million)
Table 22. Asia Pacific Breast Cancer Screening Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 23. China Breast Cancer Screening Market, by Test Type – Revenue and Forecast to 2027 (USD Million)
Table 24. China Breast Cancer Screening Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 25. Japan Breast Cancer Screening Market, by Test Type – Revenue and Forecast to 2027 (USD Million)
Table 26. Japan Breast Cancer Screening Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 27. IndiaBreast Cancer Screening Market, by Test Type – Revenue and Forecast to 2027 (USD Million)
Table 28. IndiaBreast Cancer Screening Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 29. South Korea Breast Cancer Screening Market, by Test Type – Revenue and Forecast to 2027 (USD Million)
Table 30. South Korea Breast Cancer Screening Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 31. Australia Breast Cancer Screening Market, by Test Type – Revenue and Forecast to 2027 (USD Million)
Table 32. Australia Breast Cancer Screening Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 33. Middle East & Africa Breast Cancer Screening Market, by Test Type– Revenue and Forecast to 2027 (USD Million)
Table 34. Middle East & Africa Breast Cancer Screening Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 35. Saudi Arabia Breast Cancer Screening Market, by Test Type – Revenue and Forecast to 2027 (USD Million)
Table 36. Saudi Arabia Breast Cancer Screening Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 37. UAE Breast Cancer Screening Market, by Test Type – Revenue and Forecast to 2027 (USD Million)
Table 38. UAE Breast Cancer Screening Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 39. South Africa Breast Cancer Screening Market, by Test Type – Revenue and Forecast to 2027 (USD Million)
Table 40. South Africa Breast Cancer Screening Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 41. South and Central America Breast Cancer Screening Market, by Test Type– Revenue and Forecast to 2027 (USD Million)
Table 42. South and Central America Breast Cancer Screening Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 43. Brazil Breast Cancer Screening Market, by Test Type – Revenue and Forecast to 2027 (USD Million)
Table 44. Brazil Breast Cancer Screening Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 45. Argentina Breast Cancer Screening Market, by Test Type – Revenue and Forecast to 2027 (USD Million)
Table 46. Argentina Breast Cancer Screening Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 47. Recent Inorganic Growth Strategies In The Breast Cancer Screening Market
Table 48. Recent Organic Growth Strategies In The Breast Cancer Screening Market
Table 49. Glossary of Terms, Breast Cancer Screening Market
LIST OF FIGURES
Figure 1. Breast Cancer Screening Market Segmentation
Figure 2. Breast Cancer Screening Segmentation, By Region
Figure 3. Imaging Tests Held Largest Share of Breast Cancer Screening Market
Figure 4. Asia Pacific to Register Remarkable CAGR in Market During Forecast Period
Figure 5. North America PEST Analysis
Figure 6. Europe PEST Analysis
Figure 7. Asia Pacific PEST Analysis
Figure 8. Middle East and Africa (MEA) PEST Analysis
Figure 9. South and Central America (SCAM) PEST Analysis
Figure 10. Breast Cancer Screening Market Impact Analysis Of Driver And Restraints
Figure 11. Global Breast Cancer Screening Market – Revenue Forecast and Analysis – 2019- 2027
Figure 12. Global Breast cancer screening Market – By Geography Forecast And Analysis – 2019- 2027
Figure 13. Market Positioning Of Key Players In Global Breast cancer screening Market
Figure 14. Breast Cancer Screening Market Revenue Share, by Test Type (2019 and 2027)
Figure 15. Blood Marker Tests: Breast Cancer Screening Market– Revenue and Forecast to 2027 (US$ Million)
Figure 16. Imaging Test: Breast Cancer Screening Market– Revenue and Forecast to 2027 (US$ Million)
Figure 17. Genetic Test: Breast Cancer Screening Market– Revenue and Forecast to 2027 (US$ Million)
Figure 18. Immunohistochemistry Test: Breast Cancer Screening Market – Revenue and Forecast to 2027 (US$ Million)
Figure 19. Breast Cancer Screening Market, by End-User, 2019 and 2027 (%)
Figure 20. Hospitals: Breast Cancer Screening Market – Revenue and Forecast to 2027 (US$ Million)
Figure 21. Diagnostic Centers: Breast Cancer Screening Market – Revenue and Forecast to 2027 (US$ Million)
Figure 22. Research Laboratories: Breast Cancer Screening Market – Revenue and Forecast to 2027 (US$ Million)
Figure 23. Cancer Institutes: Breast Cancer Screening Market – Revenue and Forecast to 2027 (US$ Million)
Figure 24. North America: Breast Cancer Screening Market, by Key Country – Revenue (2019) (USD Million)
Figure 25. North America Breast Cancer Screening Market Revenue and Forecast to 2027 (USD Million)
Figure 26. North America: Breast Cancer Screening Market, by Country, 2019 & 2027 (%)
Figure 27. US: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)
Figure 28. Canada: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)
Figure 29. Mexico: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)
Figure 30. Europe: Breast Cancer Screening Market, by Key Country – Revenue (2019) (USD Million)
Figure 31. Europe Breast Cancer Screening Market Revenue and Forecast to 2027 (USD Million)
Figure 32. Europe: Breast Cancer Screening Market, by Country, 2018 & 2027 (%)
Figure 33. Germany: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)
Figure 34. UK: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)
Figure 35. France: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)
Figure 36. Spain: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)
Figure 37. Italy: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)
Figure 38. Asia Pacific: Breast Cancer Screening Market, by Key Country – Revenue (2019) (USD Million)
Figure 39. Asia Pacific Breast Cancer Screening Market Revenue and Forecast to 2027 (USD Million)
Figure 40. China: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)
Figure 41. Japan: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)
Figure 42. India: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)
Figure 43. South Korea: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)
Figure 44. Australia: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)
Figure 45. Middle East & Africa: Breast Cancer Screening Market, by Key Country – Revenue (2019) (USD Million)
Figure 46. Middle East & Africa Breast Cancer Screening Market Revenue and Forecast to 2027 (USD Million)
Figure 47. Middle East & Africa: Breast Cancer Screening Market Share by Country – 2019 & 2027, (%)
Figure 48. Saudi Arabia: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)
Figure 49. UAE: Breast Cancer Screening Market – Revenue and Forecast to 2027 (US$ Million)
Figure 50. South Africa: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)
Figure 51. South and Central America: Breast Cancer Screening Market, by Key Country – Revenue (2019) (USD Million)
Figure 52. South and Central America Breast Cancer Screening Market Revenue and Forecast to 2027 (USD Million)
Figure 53. South and Central America: Breast Cancer Screening Market, by Country, 2018 & 2027 (%)
Figure 54. Brazil: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)
Figure 55. Argentina: Breast Cancer Screening Market – Revenue and Forecast to 2027 (USD Million)
Figure 56. Impact of COVID-19 Pandemic In North American Country Markets
Figure 57. Impact of COVID-19 Pandemic In European Country Markets
Figure 58. Impact of COVID-19 Pandemic In Asia Pacific Country Markets
Figure 59. Impact Of COVID-19 Pandemic In Rest of the World Countries Market
Figure 60. Growth Strategies in TheBreast Cancer Screening Market, 2016-2020
The List of Companies - Breast Cancer Screening Market
- Koninklijke Philips N.V..
- HOLOGIC, INC.
- BD
- MYRIAD GENETICS, INC.
- SIEMENS HEALTHCARE GMBH
- Exact Sciences Corporation
- ONCOCYTE CORPORATION
- POC MEDICAL SYSTEMS
- Danaher
- GENERAL ELECTRIC
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For